British Journal of Anaesthesia, 2002, Vol. 88, No. 2 166-174
© 2002 The Board of Management and Trustees of the British Journal of Anaesthesia
Clinical Investigations |
Can molecular similarity-activity models for intravenous general anaesthetics help explain their mechanism of action?
1Department of Biosciences, University of Hertfordshire, College Lane, Hatfield, Hertfordshire AL10 9AB and 2Nuffield Department of Anaesthetics, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK*Corresponding author
Background. The importance of molecular shape and electrostatic potential in determining the activities of 11 structurally-diverse i.v. general anaesthetics was investigated using computational chemistry techniques.
Methods. The free plasma anaesthetic concentrations that abolished the response to noxious stimulation were obtained from the literature. The similarities in the molecular shapes and electrostatic potentials of the agents to eltanolone (the most potent anaesthetic agent in the group) were calculated using Carbo indices, and correlated with in vivo potency.
Results. The best model obtained was based on the similarities of the anaesthetics to two eltanolone conformers (r2=0.820). This model correctly predicted the potencies of the R- and S-enantiomers of ketamine, but identified alphaxalone as an outlier. Exclusion of alphaxalone substantially improved the activity correlation (r2=0.972). A bench mark model based on octanol/water partition coefficients (r2=0.647) failed to predict the potency order of the ketamine enantiomers.
Conclusions. The results demonstrate that a single activity model can be formulated for chiral and non-chiral i.v. anaesthetic agents using molecular similarity indices.
Br J Anaesth 2002; 88: 16674
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. W. Sear What makes a molecule an anaesthetic? Studies on the mechanisms of anaesthesia using a physicochemical approach Br. J. Anaesth., July 1, 2009; 103(1): 50 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Turina, V. M. Loitto, K. Bjornstrom, T. Sundqvist, and C. Eintrei Propofol causes neurite retraction in neurones Br. J. Anaesth., September 1, 2008; 101(3): 374 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Haines, L. M. Mao, L. Yang, A. Arora, E. E. Fibuch, and J. Q. Wang Modulation of AMPA receptor GluR1 subunit phosphorylation in neurons by the intravenous anaesthetic propofol Br. J. Anaesth., May 1, 2008; 100(5): 676 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Voss, G. Ludbrook, C. Grant, R. Upton, and J. W. Sleigh A Comparison of Pharmacokinetic/Pharmacodynamic versus Mass-Balance Measurement of Brain Concentrations of Intravenous Anesthetics in Sheep Anesth. Analg., June 1, 2007; 104(6): 1440 - 1446. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Sewell and J. W. Sear Determinants of volatile general anesthetic potency: a preliminary three-dimensional pharmacophore for halogenated anesthetics. Anesth. Analg., March 1, 2006; 102(3): 764 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Sewell and J. W. Sear Derivation of Preliminary Three-Dimensional Pharmacophores for Nonhalogenated Volatile Anesthetics Anesth. Analg., September 1, 2004; 99(3): 744 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Sewell and J. W. Sear Derivation of preliminary three-dimensional pharmacophoric maps for chemically diverse intravenous general anaesthetics{dagger} Br. J. Anaesth., January 1, 2004; 92(1): 45 - 53. [Abstract] [Full Text] [PDF] |
||||

